University of North Carolina, Greensboro

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of North Carolina, Greensboro sits in the top decile of US sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count).

15 total trials 3 currently recruiting 11 completed top decile by trial count

University of North Carolina, Greensboro: 15 sponsored US clinical trials, 3 recruiting.

University of North Carolina, Greensboro sponsors 15 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 11 completed. The most-studied condition in this pipeline is Respite Care, with 1 trials.

Top-decile sponsor footprint

University of North Carolina, Greensboro ranks in the top decile of sponsors by registered trial count (#934 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

What is open in the University of North Carolina, Greensboro pipeline

3 recruiting of 15 indexed (20% open); 11 completed (73%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Respite Care (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of North Carolina, Greensboro: open-pipeline peers nationwide

Peers matched on 15 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

University of North Carolina, Greensboro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share University of North Carolina, GreensboroAllakosArbor Research Collaborative for HealthArena PharmaceuticalsArrowhead PharmaceuticalsAcera SurgicalAlign TechnologyAltruBioAlvernia University
University of North Carolina, Greensboro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of North Carolina, Greensboro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 15 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

What to do with this University of North Carolina, Greensboro page

15 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Greensboro or any single study.

  • 3 of University of North Carolina, Greensboro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Respite Care is the condition University of North Carolina, Greensboro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Respite Care trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of North Carolina, Greensboro pipeline card: 15 registered trials from official public datasets.Report a data error.